HomeCompareWHTCF vs ARCC

WHTCF vs ARCC: Dividend Comparison 2026

WHTCF yields 73.41% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WHTCF wins by $1.21M in total portfolio value
10 years
WHTCF
WHTCF
● Live price
73.41%
Share price
$2.72
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.23M
Annual income
$334,556.35
Full WHTCF calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — WHTCF vs ARCC

📍 WHTCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWHTCFARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WHTCF + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WHTCF pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WHTCF
Annual income on $10K today (after 15% tax)
$6,239.68/yr
After 10yr DRIP, annual income (after tax)
$284,372.90/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, WHTCF beats the other by $284,371.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WHTCF + ARCC for your $10,000?

WHTCF: 50%ARCC: 50%
100% ARCC50/50100% WHTCF
Portfolio after 10yr
$627.8K
Annual income
$167,278.76/yr
Blended yield
26.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

WHTCF
Analyst Ratings
2
Buy
1
Hold
Consensus: Buy
Altman Z
1.3
Piotroski
6/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WHTCF buys
0
ARCC buys
0
No recent congressional trades found for WHTCF or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWHTCFARCC
Forward yield73.41%10.82%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$1.23M$24.5K
Annual income after 10y$334,556.35$1.16
Total dividends collected$1.06M$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: WHTCF vs ARCC ($10,000, DRIP)

YearWHTCF PortfolioWHTCF Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$18,041$7,340.80$11,381$541.15+$6.7KWHTCF
2$31,681$12,376.99$12,621$284.08+$19.1KWHTCF
3$54,211$20,312.79$13,827$145.31+$40.4KWHTCF
4$90,491$32,484.78$15,062$73.43+$75.4KWHTCF
5$147,502$50,677.10$16,364$36.89+$131.1KWHTCF
6$235,028$77,200.91$17,757$18.49+$217.3KWHTCF
7$366,444$114,963.60$19,258$9.25+$347.2KWHTCF
8$559,614$167,518.98$20,880$4.63+$538.7KWHTCF
9$837,877$239,089.96$22,636$2.32+$815.2KWHTCF
10$1,231,084$334,556.35$24,539$1.16+$1.21MWHTCF

WHTCF vs ARCC: Complete Analysis 2026

WHTCFStock

WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers end-to-end omni-channel patient services, including primary care; physiotherapy, occupational therapy, chiropractic, dietary, mental health counselling, and sleep related services; specialized care, including gastroenterologists; diagnostic services related to cardiology, women's health, and bone/muscle health and cancer diagnostics; and telehealth services. The company also operates OSCAR Pro, an electronic medical records platform; telehealth platforms, including Tia Health, VirtualClinic+, VirtuelMed, Adracare, and Circle Medical; Apps.health, a digital health app marketplace; Insig, which offers virtual care and digital patient engagement services; billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions. As of December 31, 2021, the company operated 30 primary care and executive care clinics; and provides primary care, specialty care, and accredited diagnostic health services through 49 locations across Ontario. The company was formerly known as Wellness Lifestyles Inc. and changed its name to WELL Health Technologies Corp. in July 2018. WELL Health Technologies Corp. was incorporated in 2010 and is headquartered in Vancouver, Canada.

Full WHTCF Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this WHTCF vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WHTCF vs SCHDWHTCF vs JEPIWHTCF vs OWHTCF vs KOWHTCF vs MAINWHTCF vs HTGCWHTCF vs GBDCWHTCF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.